Associate Professor of Medicine

Director, Adult Cystic Fibrosis Program

Dr. Noah Lechtzin is an associate professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health. His areas of clinical expertise include amyotrophic lateral sclerosis (ALS), cystic fibrosis, adult pulmonary disease and critical care medicine. Dr. Lechtzin serves as director of the Adult Cystic Fibrosis Program.

Dr. Lechtzin graduated first in his medical school class at Temple University, then did his internship and residency in internal medicine at Johns Hopkins. He completed a fellowship in pulmonary and critical care medicine at Johns Hopkins and also received an M.H.A. from the Johns Hopkins Bloomberg School of Public Health.

His research interests include the impact of antibiotic-resistant bacterial infections in cystic fibrosis (CF) patients and metabolic complications in CF, including vitamin D deficiency, osteoporosis and testosterone deficiency.

Expertise

• Amyotrophic Lateral Sclerosis (ALS)
• Cystic Fibrosis
• Pulmonary Disease
• Critical Care Medicine

Research Interests

• The metabolic complications in CF, including vitamin D deficiency, osteoporosis and testosterone deficiency
• The impact of antibiotic resistant bacterial infections in CF patients

Board Certification

• Internal Medicine
• Pulmonary and Critical Care Medicine